{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["AKT", "Bax/Bcl-2/caspases pathway", "Peucedanum tauricum", "apoptosis", "bergapten", "cell cycle block in G2 phase", "colorectal adenocarcinoma (HT-29 and SW620)", "multiple myeloma (RPMI8226 and U266)", "osteosarcoma (Saos-2 and HOS)"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": ["IM"], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "37958539", "DateCompleted": {"Year": "2023", "Month": "11", "Day": "15"}, "DateRevised": {"Year": "2023", "Month": "11", "Day": "22"}, "Article": {"ArticleDate": [{"Year": "2023", "Month": "10", "Day": "25"}], "Language": ["eng"], "ELocationID": ["15555", "10.3390/ijms242115555"], "Journal": {"ISSN": "1422-0067", "JournalIssue": {"Volume": "24", "Issue": "21", "PubDate": {"Year": "2023", "Month": "Oct", "Day": "25"}}, "Title": "International journal of molecular sciences", "ISOAbbreviation": "Int J Mol Sci"}, "ArticleTitle": "Evaluation of the Biological Effect of Non-UV-Activated Bergapten on Selected Human Tumor Cells and the Insight into the Molecular Mechanism of Its Action.", "Abstract": {"AbstractText": ["There is some evidence that non-photoactivated psoralens may be active against breast and colon tumor cells. Therefore, we evaluated the antiproliferative, proapoptotic, and anti-migrative effect of 5-methoxypsoralen (5-MOP) isolated from <i>Peucedanum tauricum</i> MB fruits in human colorectal adenocarcinoma (HT-29 and SW620), osteosarcoma (Saos-2 and HOS), and multiple myeloma (RPMI8226 and U266). Dose- and cell-line-dependent effects of 5-MOP on viability and proliferation were observed, with the strongest inhibitory effect against Saos-2 and a moderate effect against the HOS, HT-29, and SW620 cells. Multiple myeloma showed low sensitivity. The high viability of human normal cell cultures (HSF and hFOB) in a wide range of 5-MOP concentrations tested (6.25-100 \u00b5M) was confirmed. Moreover, the migration of treated Saos-2, SW620, and HT-29 cell lines was impaired, as indicated via a wound healing assay. Flow cytometry analysis conducted on Saos-2 cells revealed the ability of 5-MOP to block the cell cycle in the G2 phase and trigger apoptosis, which was accompanied by a loss of mitochondrial membrane potential, caspases (-9 and -3) activation, the altered expression of the Bax and Bcl-2 proteins, and decreased AKT phosphorylation. This is the first report evaluating the antiproliferative and antimigratory impact of non-UV-activated bergapten on the abovementioned (except for HT-29) tumor cells, which provides new data on the potential role of 5-MOP in inhibiting the growth of various types of therapeutic-resistant cancers."]}, "AuthorList": [{"Identifier": ["0000-0002-3255-0635"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacognosy with Medicinal Plants Garden, Medical University of Lublin, Chod\u017aki 1 Street, 20-093 Lublin, Poland."}], "LastName": "Bartnik", "ForeName": "Magdalena", "Initials": "M"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Cell Biology, Institute of Biological Sciences, Maria Curie-Sk\u0142odowska University, Akademicka 19 Street, 20-033 Lublin, Poland."}], "LastName": "S\u0142awi\u0144ska-Brych", "ForeName": "Adrianna", "Initials": "A"}, {"Identifier": ["0000-0003-2364-6181"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Virology and Immunology, Institute of Biological Sciences, Maria Curie-Sk\u0142odowska University, Akademicka 19 Street, 20-033 Lublin, Poland."}], "LastName": "Mizerska-Kowalska", "ForeName": "Magdalena", "Initials": "M"}, {"Identifier": ["0000-0002-0920-3192"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Virology and Immunology, Institute of Biological Sciences, Maria Curie-Sk\u0142odowska University, Akademicka 19 Street, 20-033 Lublin, Poland."}], "LastName": "Zdzisi\u0144ska", "ForeName": "Barbara", "Initials": "B"}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "Switzerland", "MedlineTA": "Int J Mol Sci", "NlmUniqueID": "101092791", "ISSNLinking": "1422-0067"}, "ChemicalList": [{"RegistryNumber": "4FVK84C92X", "NameOfSubstance": "5-Methoxypsoralen"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": ["pharmacology"], "DescriptorName": "5-Methoxypsoralen"}, {"QualifierName": [], "DescriptorName": "Cell Proliferation"}, {"QualifierName": [], "DescriptorName": "Multiple Myeloma"}, {"QualifierName": [], "DescriptorName": "Apoptosis"}, {"QualifierName": ["pathology"], "DescriptorName": "Bone Neoplasms"}, {"QualifierName": [], "DescriptorName": "Cell Line, Tumor"}], "CoiStatement": "The authors declare no conflict of interest. The funders had no role in the design of the study, in the collection, analyses, or interpretation of data, in the writing of the manuscript, or in the decision to publish the results."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "J\u00f6hrer K., Cicek S.S. Multiple Myeloma Inhibitory Activity of Plant Natural Products. Cancers. 2021;13:2678. doi: 10.3390/cancers13112678.", "ArticleIdList": ["10.3390/cancers13112678", "PMC8198565", "34072312"]}, {"Citation": "De Rosa M., Rega D., Costabile V., Duraturo F., Niglio A., Izzo P., Pace U., Delrio P. The biological complexity of colorectal cancer: Insights into biomarkers for early detection and personalized care. Ther. Adv. Gastroenterol. 2016;9:861\u2013886. doi: 10.1177/1756283X16659790.", "ArticleIdList": ["10.1177/1756283X16659790", "PMC5076770", "27803741"]}, {"Citation": "De Luca A., Bellavia D., Raimondi L., Carina V., Costa V., Fini M., Giavaresi G. Multiple Effects of Resveratrol on Osteosarcoma Cell Lines. Pharmaceuticals. 2022;15:342. doi: 10.3390/ph15030342.", "ArticleIdList": ["10.3390/ph15030342", "PMC8956103", "35337142"]}, {"Citation": "Raimondi L., De Luca A., Gallo A., Costa V., Russelli G., Cuscino N., Manno M., Raccosta S., Carina V., Bellavia D., et al. Osteosarcoma cell-derived exosomes affect tumor microenvironment by specific packaging of microRNAs. Carcinogenesis. 2020;41:666\u2013677. doi: 10.1093/carcin/bgz130.", "ArticleIdList": ["10.1093/carcin/bgz130", "31294446"]}, {"Citation": "Nobili S., Lippi D., Witort E., Donnini M., Bausi L., Mini E., Capaccioli S. Natural compounds for cancer treatment and prevention. Pharmacol. Res. 2009;59:365\u2013378. doi: 10.1016/j.phrs.2009.01.017.", "ArticleIdList": ["10.1016/j.phrs.2009.01.017", "19429468"]}, {"Citation": "Dholwani K.K., Saluja A.K., Gupta A.R., Shah D.R. A review on plant-derived natural products and their analogs with anti-tumor activity. Indian J. Pharmacol. 2008;40:49\u201358. doi: 10.4103/0253-7613.41038.", "ArticleIdList": ["10.4103/0253-7613.41038", "PMC3025126", "21279166"]}, {"Citation": "Xiao Q., Zhu W., Feng W., Lee S.S., Leung A.W., Shen J., Gao L., Xu C. A Review of Resveratrol as a Potent Chemoprotective and Synergistic Agent in Cancer Chemotherapy. Front. Pharmacol. 2018;9:1534. doi: 10.3389/fphar.2018.01534.", "ArticleIdList": ["10.3389/fphar.2018.01534", "PMC6333683", "30687096"]}, {"Citation": "Yuan H., Ma Q., Ye L., Piao G. The Traditional Medicine and Modern Medicine from Natural Products. Molecules. 2016;21:559. doi: 10.3390/molecules21050559.", "ArticleIdList": ["10.3390/molecules21050559", "PMC6273146", "27136524"]}, {"Citation": "Sumorek-Wiadro J., Zaj\u0105c A., Maciejczyk A., Jakubowicz-Gil J. Furanocoumarins in anticancer therapy\u2014For and against. Fitoterapia. 2020;142:104492. doi: 10.1016/j.fitote.2020.104492.", "ArticleIdList": ["10.1016/j.fitote.2020.104492", "32032635"]}, {"Citation": "Viola G., Fortunato E., Cecconet L., Disar\u00f2 S., Basso G. Induction of apoptosis in Jurkat cells by photoexcited psoralen derivatives: Implication of mitochondrial dysfunctions and caspases activation. Toxicol. Vitr. 2007;21:211\u2013216. doi: 10.1016/j.tiv.2006.09.016.", "ArticleIdList": ["10.1016/j.tiv.2006.09.016", "17084583"]}, {"Citation": "Mi C., Ma J., Wang K.S., Zuo H.X., Wang Z., Li M.Y., Piao L.X., Xu G.H., Li X., Quan Z.S., et al. Imperatorin suppresses proliferation and angiogenesis of human colon cancer cell by targeting HIF-1\u03b1 via the mTOR/p70S6K/4E-BP1 and MAPK pathways. J. Ethnopharmacol. 2017;203:27\u201328. doi: 10.1016/j.jep.2017.03.033.", "ArticleIdList": ["10.1016/j.jep.2017.03.033", "28341244"]}, {"Citation": "Tiberio P., Cavadini E., Callari M., Daidone M.G., Appierto V. AF1q: A novel mediator of basal and 4-HPR-induced apoptosis in ovarian cancer cells. PLoS ONE. 2012;7:e39968. doi: 10.1371/journal.pone.0039968.", "ArticleIdList": ["10.1371/journal.pone.0039968", "PMC3383705", "22761939"]}, {"Citation": "Bartnik M., S\u0142awi\u0144ska-Brych A., \u017burek A., Kandefer-Szersze\u0144 M., Zdzisi\u0144ska B. 8-methoxypsoralen reduces AKT phosphorylation, induces intrinsic and extrinsic apoptotic pathways, and suppresses cell growth of SK-N-AS neuroblastoma and SW620 metastatic colon cancer cells. J. Ethnopharmacol. 2017;207:19\u201329. doi: 10.1016/j.jep.2017.06.010.", "ArticleIdList": ["10.1016/j.jep.2017.06.010", "28627461"]}, {"Citation": "Nie C., Luo Y., Zhao X., Luo N., Tong A., Liu X., Yuan Z., Wang C., Wei Y. Caspase-9 mediates Puma activation in UCN-01-induced apoptosis. Cell Death Dis. 2014;5:e1495. doi: 10.1038/cddis.2014.461.", "ArticleIdList": ["10.1038/cddis.2014.461", "PMC4649536", "25356864"]}, {"Citation": "Feinman R., Koury J., Thames M., Barlogie B., Epstein J., Siegel D.S. Role of NF-\u03baB in the rescue of multiple myeloma cells from glucocorticoid-induced apoptosis by bcl-2. Blood. 1999;93:3044\u20133052. doi: 10.1182/blood.V93.9.3044.", "ArticleIdList": ["10.1182/blood.V93.9.3044", "10216101"]}, {"Citation": "Tian Y., Shi R., Gao M., Wang H., Du Y., Zhang L., Wang O., Zhang M. Differentiation of Furanocoumarin Isomers with Ratio of Relative Abundance of Characteristic Fragment Ions and Application in Angelicae dahuricae Radix. Chromatographia. 2017;80:1401\u20131410. doi: 10.1007/s10337-017-3348-5.", "ArticleIdList": ["10.1007/s10337-017-3348-5"]}, {"Citation": "Bartnik M. Efficient Separation of the Methoxyfuranocoumarins Peucedanin, 8-Methoxypeucedanin, and Bergapten by Centrifugal Partition Chromatography (CPC) Molecules. 2023;28:1923. doi: 10.3390/molecules28041923.", "ArticleIdList": ["10.3390/molecules28041923", "PMC9967691", "36838916"]}, {"Citation": "Manoli I., Alesci S., Blackman M.R., Su Y.A., Rennert O.M., Chrousos G.P. Mitochondria as key components of the stress response. Trends Endocr. Metabol. 2007;18:190\u2013198. doi: 10.1016/j.tem.2007.04.004.", "ArticleIdList": ["10.1016/j.tem.2007.04.004", "17500006"]}, {"Citation": "Lee H.-C., Pen-Hui Yin P.-H., Lu C.-Y., Chi C.-W., Wei Y.-H. Increase of mitochondria and mitochondrial DNA in response to oxidative stress in human cells. Biochem. J. 2000;348:425\u2013432. doi: 10.1042/bj3480425.", "ArticleIdList": ["10.1042/bj3480425", "PMC1221082", "10816438"]}, {"Citation": "Jan R., Chaudhry G.-E.-S. Understanding Apoptosis and Apoptotic Pathways Targeted Cancer Therapeutics. Adv. Pharm. Bull. 2019;9:205\u2013218. doi: 10.15171/apb.2019.024.", "ArticleIdList": ["10.15171/apb.2019.024", "PMC6664112", "31380246"]}, {"Citation": "Choudhari A.S., Mandave P.C., Deshpande M., Ranjekar P., Prakash O. Phytochemicals in Cancer Treatment: From Preclinical Studies to Clinical Practice. Front. Pharmacol. 2020;10:1614. doi: 10.3389/fphar.2019.01614. Erratum in Front. Pharmacol. 2020, 11, 175.", "ArticleIdList": ["10.3389/fphar.2019.01614", "PMC7025531", "32116665"]}, {"Citation": "Wang F.M., Galson D.L., Roodman G.D., Ouyang H. Resveratrol triggers the pro-apoptotic endoplasmic reticulum stress response and represses pro-survival XBP1 signaling in human multiple myeloma cells. Exp. Hematol. 2011;39:999\u20131006. doi: 10.1016/j.exphem.2011.06.007.", "ArticleIdList": ["10.1016/j.exphem.2011.06.007", "PMC3261654", "21723843"]}, {"Citation": "Dai Y., Khanna P., Chen S., Pei X.Y., Dent P., Grant S. Statins synergistically potentiate 7-hydroxystaurosporine (UCN-01) lethality in human leukemia and myeloma cells by disrupting Ras farnesylation and activation. Blood. 2007;109:4415\u20134423. doi: 10.1182/blood-2006-09-047076.", "ArticleIdList": ["10.1182/blood-2006-09-047076", "PMC1885487", "17264303"]}, {"Citation": "Lee Y.M., Wu T.H., Chen S.F., Chung J.G. Effect of 5-methoxypsoralen (5-MOP) on cell apoptosis and cell cycle in human hepatocellular carcinoma cell line. Toxicol. Vitr. 2003;17:279\u2013287. doi: 10.1016/S0887-2333(03)00014-6.", "ArticleIdList": ["10.1016/S0887-2333(03)00014-6", "12781206"]}, {"Citation": "Aung T.N., Qu Z., Kortschak R.D., Adelson D.L. Understanding the Effectiveness of Natural Compound Mixtures in Cancer through Their Molecular Mode of Action. Int. J. Mol. Sci. 2017;18:656. doi: 10.3390/ijms18030656.", "ArticleIdList": ["10.3390/ijms18030656", "PMC5372668", "28304343"]}, {"Citation": "Deeni Y.Y., Ibbotson S.H., Woods J.A., Wolf C.R., Smith G. Cytochrome P450 CYP1B1 interacts with 8-methoxypsoralen (8-MOP) and influences psoralen-ultraviolet A (PUVA) sensitivity. PLoS ONE. 2013;8:e75494. doi: 10.1371/journal.pone.0075494.", "ArticleIdList": ["10.1371/journal.pone.0075494", "PMC3781062", "24086543"]}, {"Citation": "Quetglas-Llabr\u00e9s M.M., Quispe C., Herrera-Bravo J., Catarino M.D., Pereira O.R., Cardoso S.M., Dua K., Chellappan D.K., Pabreja K., Satija S., et al. Pharmacological Properties of Bergapten: Mechanistic and Therapeutic Aspects. Oxid. Med. Cell Longev. 2022;2022:8615242. doi: 10.1155/2022/8615242.", "ArticleIdList": ["10.1155/2022/8615242", "PMC9060977", "35509838"]}, {"Citation": "Liang Y., Xie L., Liu K., Cao Y., Dai X., Wang X., Lu J., Zhang X., Li X. Bergapten: A review of its pharmacology, pharmacokinetics, and toxicity. Phytother. Res. 2021;35:6131\u20136147. doi: 10.1002/ptr.7221.", "ArticleIdList": ["10.1002/ptr.7221", "34347307"]}, {"Citation": "Yang Y., Zheng K., Mei W., Wang Y., Yu C., Yu B., Deng S., Hu J. Anti-inflammatory and proresolution activities of bergapten isolated from the roots of Ficus hirta in an in vivo zebrafish model. Biochem. Biophys. Res. Commun. 2018;496:763\u2013769. doi: 10.1016/j.bbrc.2018.01.071.", "ArticleIdList": ["10.1016/j.bbrc.2018.01.071", "29337062"]}, {"Citation": "Singh G., Kaur A., Kaur J., Bhatti M.S., Singh P., Bhatti R. Bergapten inhibits chemically induced nociceptive behavior and inflammation in mice by decreasing the expression of spinal PARP, iNOS, COX-2 and inflammatory cytokines. Inflammopharmacology. 2019;27:749\u2013760. doi: 10.1007/s10787-019-00585-6.", "ArticleIdList": ["10.1007/s10787-019-00585-6", "30953227"]}, {"Citation": "Ibbotson S. Drug and chemical induced photosensitivity from a clinical perspective. Photochem. Photobiol. Sci. 2018;17:1885\u20131903. doi: 10.1039/c8pp00011e.", "ArticleIdList": ["10.1039/c8pp00011e", "30283959"]}, {"Citation": "Sumiyoshi M., Sakanaka M., Taniguchi M., Baba K., Kimura Y. Anti-tumor effects of various furanocoumarins isolated from the roots, seeds and fruits of Angelica and Cnidium species under ultraviolet A irradiation. J. Nat. Med. 2014;68:83\u201394. doi: 10.1007/s11418-013-0774-z.", "ArticleIdList": ["10.1007/s11418-013-0774-z", "23649674"]}, {"Citation": "Stern R.S. PUVA Follow-Up Study. The risk of squamous cell and basal cell cancer associated with psoralen and ultraviolet A therapy: A 30-year prospective study. J. Am. Acad. Dermatol. 2012;66:553\u2013562. doi: 10.1016/j.jaad.2011.04.004.", "ArticleIdList": ["10.1016/j.jaad.2011.04.004", "22264671"]}, {"Citation": "Dowdy J.C., Sayre R.M. Melanoma Risk From Dietary Furocoumarins: How Much More Evidence Is Required? J. Clin. Oncol. 2016;34:636\u2013637. doi: 10.1200/JCO.2015.63.8643.", "ArticleIdList": ["10.1200/JCO.2015.63.8643", "26729442"]}, {"Citation": "Panno M.L., Giordano F., Palma M.G., Bartella V., Rago V., Maggiolini M., Sisci D., Lanzino M., De Amicis F., And\u00f2 S. Evidence that bergapten, independently of its photoactivation, enhances p53 gene expression and induces apoptosis in human breast cancer cells. Curr. Cancer Drug Targets. 2009;9:469\u2013481. doi: 10.2174/156800909788486786.", "ArticleIdList": ["10.2174/156800909788486786", "19519316"]}, {"Citation": "Ahmed S., Khan H., Aschner M., Mirzae H., K\u00fcpeli Akkol E., Capasso R. Anticancer Potential of Furanocoumarins: Mechanistic and Therapeutic Aspects. Int. J. Mol. Sci. 2020;21:5622. doi: 10.3390/ijms21165622.", "ArticleIdList": ["10.3390/ijms21165622", "PMC7460698", "32781533"]}, {"Citation": "Fujioka T., Furumi K., Fujii H., Okabe H., Mihashi K., Nakano Y., Matsunaga H., Katano M., Mori M. Antiproliferative constituents from Umbelliferae plants. V. A new furanocoumarin and falcarindiol furanocoumarin ethers from the root of Angelica japonica. Chem. Pharm. Bull. 1999;47:96\u2013100. doi: 10.1248/cpb.47.96.", "ArticleIdList": ["10.1248/cpb.47.96", "9987830"]}, {"Citation": "Girennavar B. Ph.D. Thesis. Texas A&M University; College Station, TX, USA: 2007. Grapefruit-Drug Interactions: Isolation, Synthesis, and Biological Activities of Furanocoumarins and Their Variation Due to Pre- and Post-Harvest Factors; pp. 113\u2013115."}, {"Citation": "Um Y.R., Kong C., Lee J.I., Kim Y.A., Nam T.J., Seo Y. Evaluation of chemical constituents from Glehnia littoralis for antiproliferative activity against HT-29 human colon cancer cells. Process Biochem. 2010;45:114\u2013119. doi: 10.1016/j.procbio.2009.08.016.", "ArticleIdList": ["10.1016/j.procbio.2009.08.016"]}, {"Citation": "Panno M.L., Giordano F., Mastroianni F., Palma M.G., Bartella V., Carpino A., Aquila S., And\u00f2 S. Breast cancer cell survival signal is affected by bergapten combined with an ultraviolet irradiation. FEBS Lett. 2010;584:2321\u20132326. doi: 10.1016/j.febslet.2010.04.001.", "ArticleIdList": ["10.1016/j.febslet.2010.04.001", "20371365"]}, {"Citation": "Guo H., He Y., Bu C., Peng Z. Antitumor and apoptotic effects of 5-methoxypsoralen in U87MG human glioma cells and its effect on cell cycle, autophagy and PI3K/Akt signaling pathway. Arch. Med. Sci. 2019;15:1530\u20131538. doi: 10.5114/aoms.2019.81729.", "ArticleIdList": ["10.5114/aoms.2019.81729", "PMC6855158", "31749882"]}, {"Citation": "Chiang S.R., Lin C.S., Lin H.H., Shieh P.C., Kao S.H. Bergapten induces G1 arrest of non-small cell lung cancer cells, associated with the p53-mediated cascade. Mol. Med. Rep. 2019;19:1972\u20131978. doi: 10.3892/mmr.2019.9810.", "ArticleIdList": ["10.3892/mmr.2019.9810", "30628674"]}, {"Citation": "Liu W.X., Jia F.L., He Y.Y., Zhang B.X. Protective effects of 5-methoxypsoralen against acetaminophen-induced hepatotoxicity in mice. World J. Gastroenterol. 2012;18:2197\u20132202. doi: 10.3748/wjg.v18.i18.2197.", "ArticleIdList": ["10.3748/wjg.v18.i18.2197", "PMC3351769", "22611312"]}, {"Citation": "De Oliveira D.M., de Farias M.T., Teles A.L., Dos Santos Junior M.C., de Cerqueira M.D., Lima R.M., El-Bach\u00e1 R.S. 8-Methoxypsoralen is a competitive inhibitor of glutathione S-transferase P1-1. Front. Cell. Neurosci. 2014;8:308. doi: 10.3389/fncel.2014.00308.", "ArticleIdList": ["10.3389/fncel.2014.00308", "PMC4179718", "25324722"]}, {"Citation": "Pattanayak S.P., Bose P., Sunita P., Siddique M.U.M., Lapenna A. Bergapten inhibits liver carcinogenesis by modulating LXR/PI3K/Akt and IDOL/LDLR pathways. Biomed. Pharmacother. 2018;108:297\u2013308. doi: 10.1016/j.biopha.2018.08.145.", "ArticleIdList": ["10.1016/j.biopha.2018.08.145", "30227322"]}, {"Citation": "Lin C.P., Lin C.S., Lin H.H., Li K.T., Kao S.H., Tsao S.M. Bergapten induces G1 arrest and pro-apoptotic cascade in colorectal cancer cells associating with p53/p21/PTEN axis. Environ. Toxicol. 2019;34:303\u2013311. doi: 10.1002/tox.22685.", "ArticleIdList": ["10.1002/tox.22685", "30576070"]}, {"Citation": "Via L.D., Gia O., Magno S.M., Santana L., Teijeira M., Uriarte E. New tetracyclic analogues of photochemotherapeutic drugs 5-MOP and 8-MOP: Synthesis, DNA interaction, and antiproliferative activity. J. Med. Chem. 1999;42:4405\u20134413. doi: 10.1021/jm9910829.", "ArticleIdList": ["10.1021/jm9910829", "10543884"]}, {"Citation": "Lin S.R., Chang C.H., Hsu C.F., Tsai M.J., Cheng H., Leong M.K., Sung P.J., Chen J.C., Weng C.F. Natural compounds as potential adjuvants to cancer therapy: Preclinical evidence. Br. J. Pharmacol. 2020;177:1409\u20131423. doi: 10.1111/bph.14816.", "ArticleIdList": ["10.1111/bph.14816", "PMC7056458", "31368509"]}, {"Citation": "De Amicis F., Aquila S., Morelli C., Guido C., Santoro M., Perrotta I., Mauro L., Giordano F., Nigro A., And\u00f2 S., et al. Bergapten drives autophagy through the up-regulation of PTEN expression in breast cancer cells. Mol. Cancer. 2015;14:130. doi: 10.1186/s12943-015-0403-4.", "ArticleIdList": ["10.1186/s12943-015-0403-4", "PMC4498523", "26148846"]}, {"Citation": "Kroemer G., Galluzzi L., Brenner C. Mitochondrial membrane permeabilization in cell death. Physiol. Rev. 2007;87:99\u2013163. doi: 10.1152/physrev.00013.2006.", "ArticleIdList": ["10.1152/physrev.00013.2006", "17237344"]}, {"Citation": "Edlich F. BCL-2 proteins and apoptosis: Recent insights and unknowns. Biochem. Biophys. Res. Commun. 2018;500:26\u201334. doi: 10.1016/j.bbrc.2017.06.190.", "ArticleIdList": ["10.1016/j.bbrc.2017.06.190", "28676391"]}, {"Citation": "Jiang N., Dai Q., Su X., Fu J., Feng X., Peng J. Role of PI3K/AKT pathway in cancer: The framework of malignant behavior. Mol. Biol. Rep. 2020;47:4587\u20134629. doi: 10.1007/s11033-020-05435-1.", "ArticleIdList": ["10.1007/s11033-020-05435-1", "PMC7295848", "32333246"]}, {"Citation": "West K.A., Castillo S.S., Dennis P.A. Activation of the PI3K/Akt pathway and chemotherapeutic resistance. Drug Resist. Updat. 2002;5:234\u2013248. doi: 10.1016/S1368-7646(02)00120-6.", "ArticleIdList": ["10.1016/S1368-7646(02)00120-6", "12531180"]}, {"Citation": "Rascio F., Spadaccino F., Rocchetti M.T., Castellano G., Stallone G., Netti G.S., Ranieri E. The Pathogenic Role of PI3K/AKT Pathway in Cancer Onset and Drug Resistance: An Updated Review. Cancers. 2021;13:3949. doi: 10.3390/cancers13163949.", "ArticleIdList": ["10.3390/cancers13163949", "PMC8394096", "34439105"]}, {"Citation": "Zhang Y., Weng Q., Han J., Chen J. Alantolactone suppresses human osteosarcoma through the PI3K/AKT signaling pathway. Mol. Med. Rep. 2020;21:675\u2013684. doi: 10.3892/mmr.2019.10882.", "ArticleIdList": ["10.3892/mmr.2019.10882", "PMC6947914", "31974628"]}, {"Citation": "Bishop M.W., Janeway K.A. Emerging concepts for PI3K/mTOR inhibition as a potential treatment for osteosarcoma. F1000Research. 2016;5:F1000 Faculty Rev-1590. doi: 10.12688/f1000research.8228.1.", "ArticleIdList": ["10.12688/f1000research.8228.1", "PMC4937817", "27441088"]}, {"Citation": "Zhou Y., Zhu L.B., Peng A.F., Wang T.F., Long X.H., Gao S., Zhou R.P., Liu Z.L. LY294002 inhibits the malignant phenotype of osteosarcoma cells by modulating the phosphatidylinositol 3-kinase/Akt/fatty acid synthase signaling pathway in vitro. Mol. Med. Rep. 2015;11:1352\u20131357. doi: 10.3892/mmr.2014.2787.", "ArticleIdList": ["10.3892/mmr.2014.2787", "25351625"]}, {"Citation": "Zaj\u0105c A., Sumorek-Wiadro J., Maciejczyk A., Langner E., Wertel I., Rzeski W., Jakubowicz-Gil J. LY294002 and sorafenib as inhibitors of intracellular survival pathways in the elimination of human glioma cells by programmed cell death. Cell Tissue Res. 2021;386:17\u201328. doi: 10.1007/s00441-021-03481-0.", "ArticleIdList": ["10.1007/s00441-021-03481-0", "PMC8526469", "34236519"]}, {"Citation": "Park C., Cha H.J., Lee H., Hwang-Bo H., Ji S.Y., Kim M.Y., Hong S.H., Jeong J.W., Han M.H., Choi S.H., et al. Induction of G2/MCell Cycle Arrest and Apoptosis by Genistein in Human Bladder Cancer T24 Cells through Inhibition of the ROS-Dependent PI3k/Akt Signal Transduction Pathway. Antioxidants. 2019;8:327. doi: 10.3390/antiox8090327.", "ArticleIdList": ["10.3390/antiox8090327", "PMC6769882", "31438633"]}, {"Citation": "Liang C., Li H., Shen C., Lai J., Shi Z., Liu B., Tao H.M. Genistein potentiates the anti-cancer effects of gemcitabine in human osteosarcoma via the downregulation of Akt and nuclear factor-_B pathway. Antican. Agents Med. Chem. 2012;12:554\u2013563. doi: 10.2174/187152012800617867.", "ArticleIdList": ["10.2174/187152012800617867", "22263786"]}, {"Citation": "Fares J., Fares M.Y., Khachfe H.H., Salhab H.A., Fares Y. Molecular principles of metastasis: A hallmark of cancer revisited. Signal Transduct. Target. Ther. 2020;5:28. doi: 10.1038/s41392-020-0134-x.", "ArticleIdList": ["10.1038/s41392-020-0134-x", "PMC7067809", "32296047"]}, {"Citation": "Welch D.R., Hurst D.R. Defining the Hallmarks of Metastasis. Cancer Res. 2019;79:3011\u20133027. doi: 10.1158/0008-5472.CAN-19-0458.", "ArticleIdList": ["10.1158/0008-5472.CAN-19-0458", "PMC6571042", "31053634"]}, {"Citation": "Zhang Y., Wan Y., Huo B., Li B., Jin Y., Hu X. Extracts and components of Ficus carica leaves suppress survival, cell cycle, and migration of triple-negative breast cancer MDA-MB-231 cells. OncoTargets Ther. 2018;11:4377\u20134386. doi: 10.2147/OTT.S171601.", "ArticleIdList": ["10.2147/OTT.S171601", "PMC6067789", "30100743"]}, {"Citation": "Lauvrak S.U., Munthe E., Kresse S.H., Stratford E.W., Naml\u00f8s H.M., Meza-Zepeda L.A., Myklebost O. Functional characterization of osteosarcoma cell lines and identification of mRNAs and miRNAs associated with aggressive cancer phenotypes. Br. J. Cancer. 2013;109:2228\u20132236. doi: 10.1038/bjc.2013.549.", "ArticleIdList": ["10.1038/bjc.2013.549", "PMC3798956", "24064976"]}, {"Citation": "Zhu X.L., Liang L., Ding Y.Q. Expression of FMNL2 and its relation to the metastatic potential of human colorectal cancer cells. Nan Fang Yi Ke Da Xue Xue Bao. 2008;28:1775\u20131778.", "ArticleIdList": ["18971169"]}, {"Citation": "Jiang S., Zhou F., Zhang Y., Zhou W., Zhu L., Zhang M., Luo J., Ma R., Xu X., Zhu J., et al. Identification of tumorigenicity-associated genes in osteosarcoma cell lines based on bioinformatic analysis and experimental validation. J. Cancer. 2020;11:3623\u20133633. doi: 10.7150/jca.37393.", "ArticleIdList": ["10.7150/jca.37393", "PMC7150450", "32284759"]}, {"Citation": "Catalogue of Somatic Mutations in Cancer.  [(accessed on 17 October 2023)].  Available online:  https://cancer.sanger.ac.uk/cosmic."}, {"Citation": "COSMIC Cell Line Gene Mutation Profiles.  [(accessed on 17 October 2023)].  Available online:  https://maayanlab.cloud/Harmonizome/dataset/COSMIC+Cell+Line+Gene+Mutation+Profiles."}, {"Citation": "Piechowska K., Mizerska-Kowalska M., Zdzisi\u0144ska B., Cytarska J., Baranowska-\u0141\u0105czkowska A., Jaroch K., \u0141uczykowski K., P\u0142azi\u0144ski W., Bojko B., Kruszewski S., et al. Tropinone-Derived Alkaloids as Potent Anticancer Agents: Synthesis, Tyrosinase Inhibition, Mechanism of Action, DFT Calculation, and Molecular Docking Studies. Int. J. Mol. Sci. 2020;21:9050. doi: 10.3390/ijms21239050.", "ArticleIdList": ["10.3390/ijms21239050", "PMC7731314", "33260768"]}, {"Citation": "S\u0142awi\u0144ska-Brych A., Zdzisi\u0144ska B., Czerwonka A., Mizerska-Kowalska M., Dmoszy\u0144ska-Graniczka M., Stepulak A., Gago\u015b M. Xanthohumol exhibits anti-myeloma activity in vitro through inhibition of cell proliferation, induction of apoptosis via the ERK and JNK-dependent mechanism, and suppression of sIL-6R and VEGF production. Biochim. Biophys. Acta Gen. Subj. 2019;1863:129408. doi: 10.1016/j.bbagen.2019.08.001.", "ArticleIdList": ["10.1016/j.bbagen.2019.08.001", "31386885"]}, {"Citation": "S\u0142awi\u0144ska-Brych A., Kr\u00f3l S.K., Dmoszy\u0144ska-Graniczka M., Zdzisi\u0144ska B., Stepulak A., Gago\u015b M. Xanthohumol inhibits cell cycle progression and proliferation of larynx cancer cells in vitro. Chem. Biol. Interact. 2015;240:110\u2013118. doi: 10.1016/j.cbi.2015.08.008.", "ArticleIdList": ["10.1016/j.cbi.2015.08.008", "26297991"]}, {"Citation": "S\u0142awi\u0144ska-Brych A., Mizerska-Kowalska M., Kr\u00f3l S.K., Stepulak A., Zdzisi\u0144ska B. Xanthohumol Impairs the PMA-Driven Invasive Behaviour of Lung Cancer Cell Line A549 and Exerts Anti-EMT Action. Cells. 2021;10:1484. doi: 10.3390/cells10061484.", "ArticleIdList": ["10.3390/cells10061484", "PMC8231538", "34204745"]}, {"Citation": "Piaton E., Fabre M., Goubin-Versini I., Bretz-Grenier M.F., Courtade-Sa\u00efdi M., Vincent S., Belleann\u00e9e G., Thivolet F., Boutonnat J., Debaque H., et al. Technical recommendations and best practice guidelines for May-Gr\u00fcnwald-Giemsa staining: Literature review and insights from the quality assurance. Ann. Pathol. 2015;35:294\u2013305. doi: 10.1016/j.annpat.2015.05.019.", "ArticleIdList": ["10.1016/j.annpat.2015.05.019", "26188673"]}], "ReferenceList": []}], "History": [{"Year": "2023", "Month": "9", "Day": "27"}, {"Year": "2023", "Month": "10", "Day": "19"}, {"Year": "2023", "Month": "10", "Day": "23"}, {"Year": "2023", "Month": "11", "Day": "15", "Hour": "6", "Minute": "42"}, {"Year": "2023", "Month": "11", "Day": "14", "Hour": "6", "Minute": "42"}, {"Year": "2023", "Month": "11", "Day": "14", "Hour": "2", "Minute": "8"}, {"Year": "2023", "Month": "10", "Day": "25"}], "PublicationStatus": "epublish", "ArticleIdList": ["37958539", "PMC10647757", "10.3390/ijms242115555", "ijms242115555"]}}], "PubmedBookArticle": []}